CORT insider filings
CORCEPT THERAPEUTICS INC — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-10-05. Screen CORT transaction legs live →
Insider transaction summary — last 90 days
2026-07-10 to 2026-10-08, from the filings listed below: 31 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 64 legs across 22 filings by 9 insiders — 504,748 shares, $57,192,010 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 68.
- Largest priced transaction: sale of 91,167 shares @ $118.24 ($10,779,367) by MAHONEY DAVID L, filed 2026-08-20.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Mokari Atabak — Chief Financial Officer | 3 | — | 17 legs · 120,000 sh · $12,685,386 | 9 |
| Maduck Sean — See Remarks | 6 | — | 11 legs · 105,955 sh · $12,521,293 | 17 |
| MAHONEY DAVID L — Director | 1 | — | 4 legs · 103,606 sh · $12,251,411 | — |
| Vieira Roberto Wandenkolk — President, Oncology | 3 | — | 11 legs · 66,962 sh · $7,458,056 | 7 |
| Park Kimberly — Director | 1 | — | 1 leg · 26,685 sh · $3,270,169 | 3 |
| WILSON JAMES N — Director | 3 | — | 10 legs · 30,000 sh · $3,104,186 | — |
| Lyon Joseph Douglas — See Remarks | 4 | — | 6 legs · 21,540 sh · $2,471,484 | 13 |
| Guyer William — Chief Development Officer | 3 | — | 3 legs · 20,000 sh · $2,267,452 | 6 |
| Robb Gary Charles — Chief Business Officer | 5 | — | 1 leg · 10,000 sh · $1,162,572 | 12 |
| Gunn Justin Frederick — See Remarks | 2 | — | — | 1 |
Recent insider filings — CORCEPT THERAPEUTICS INC
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-05 | 4 | Vieira Roberto Wandenkolk — President, Oncology | Option exercise (M): 8,333 @ $21.63 · Sale (S): 1,100 @ $114.52 · Sale (S): 2,086 @ $115.73 · Sale (S): 5,147 @ $116.58 · Option exercise (M): 8,333 (derivative) @ $0 | EDGAR |
| 2026-10-05 | 4 | Lyon Joseph Douglas — See Remarks | Option exercise (M): 810 @ $13.56 · Sale (S): 810 @ $115.40 · Option exercise (M): 3,357 @ $13.56 · Option exercise (M): 5,833 @ $19.26 · Sale (S): 4,446 @ $115.70 · Sale (S): 4,744 @ $116.54 · +3 more | EDGAR |
| 2026-10-05 | 4 | Maduck Sean — See Remarks | Option exercise (M): 413 @ $8.27 · Sale (S): 413 @ $115.54 · Option exercise (M): 24,587 @ $8.27 · Sale (S): 15,843 @ $116.12 · Sale (S): 8,744 @ $116.55 · Option exercise (M): 413 (derivative) @ $0 · +1 more | EDGAR |
| 2026-10-05 | 4 | Gunn Justin Frederick — See Remarks | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-10-05 | 3 | Gunn Justin Frederick — See Remarks | Holdings only — no transactions reported | EDGAR |
| 2026-09-28 | 4 | Robb Gary Charles — Chief Business Officer | Gift (G): 17,100 @ $0 · Gift (G): 5,000 @ $0 · Gift (G): 5,000 @ $0 | EDGAR |
| 2026-09-18 | 4 | Vieira Roberto Wandenkolk — President, Oncology | Sale (S): 296 @ $100.82 | EDGAR |
| 2026-09-18 | 4 | Robb Gary Charles — Chief Business Officer | Option exercise (M): 17,493 @ $8.27 · Option exercise (M): 17,493 (derivative) @ $0 | EDGAR |
| 2026-09-16 | 4 | WILSON JAMES N — Director | Sale (S): 6,800 @ $110.27 · Sale (S): 400 @ $110.84 · Sale (S): 2,800 @ $111.70 | EDGAR |
| 2026-09-16 | 4 | Lyon Joseph Douglas — See Remarks | Option exercise (M): 2,596 @ $11.35 · Option exercise (M): 7,404 @ $13.56 · Sale (S): 7,812 @ $113.32 · Sale (S): 2,188 @ $114.12 · Option exercise (M): 2,596 (derivative) @ $0 · Option exercise (M): 7,404 (derivative) @ $0 | EDGAR |
| 2026-09-03 | 4 | Maduck Sean — See Remarks | Option exercise (M): 25,000 @ $8.27 · Sale (S): 11,730 @ $113.94 · Sale (S): 10,989 @ $114.71 · Sale (S): 2,281 @ $115.61 · Grant/award (A): 150 @ $113.38 · Grant/award (A): 150 @ $0 · +2 more | EDGAR |
| 2026-09-03 | 4 | Guyer William — Chief Development Officer | Grant/award (A): 164 @ $113.38 · Grant/award (A): 164 @ $0 | EDGAR |
| 2026-09-03 | 4 | Mokari Atabak — Chief Financial Officer | Grant/award (A): 138 @ $113.38 · Grant/award (A): 138 @ $0 · Tax withholding (F): 102 @ $113.38 | EDGAR |
| 2026-09-03 | 4 | Vieira Roberto Wandenkolk — President, Oncology | Grant/award (A): 138 @ $113.38 · Grant/award (A): 138 @ $0 · Tax withholding (F): 102 @ $113.38 · Option exercise (M): 58,333 @ $21.63 · Sale (S): 23,600 @ $109.35 · Sale (S): 23,770 @ $110.70 · +6 more | EDGAR |
| 2026-09-03 | 4 | Robb Gary Charles — Chief Business Officer | Grant/award (A): 164 @ $113.38 · Grant/award (A): 164 @ $0 · Tax withholding (F): 91 @ $113.38 | EDGAR |
| 2026-09-03 | 4 | Lyon Joseph Douglas — See Remarks | Grant/award (A): 130 @ $113.38 · Grant/award (A): 130 @ $0 · Tax withholding (F): 72 @ $113.38 | EDGAR |
| 2026-08-28 | 4 | Park Kimberly — Director | Option exercise (M): 30,000 @ $13.49 · Tax withholding (F): 3,315 @ $122.09 · Sale (S): 26,685 @ $122.55 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2026-08-27 | 4 | Maduck Sean — See Remarks | Option exercise (M): 30,955 @ $11.35 · Sale (S): 25,085 @ $125.47 · Sale (S): 5,870 @ $126.06 · Option exercise (M): 30,955 (derivative) @ $0 | EDGAR |
| 2026-08-20 | 4 | MAHONEY DAVID L — Director | Sale (S): 4,984 @ $117.47 · Sale (S): 91,167 @ $118.24 · Sale (S): 7,055 @ $118.88 · Sale (S): 400 @ $119.64 | EDGAR |
| 2026-08-18 | 4 | Robb Gary Charles — Chief Business Officer | Gift (G): 125 @ $0 · Sale (S): 10,000 @ $116.26 | EDGAR |
| 2026-08-18 | 4 | WILSON JAMES N — Director | Sale (S): 3,053 @ $110.49 · Sale (S): 4,668 @ $111.44 · Sale (S): 2,279 @ $112.64 | EDGAR |
| 2026-08-18 | 4 | Maduck Sean — See Remarks | Option exercise (M): 3,664 @ $8.27 · Sale (S): 3,664 @ $114.49 · Option exercise (M): 3,664 (derivative) @ $0 | EDGAR |
| 2026-08-14 | 4 | Robb Gary Charles — Chief Business Officer | Gift (G): 11,530 @ $0 · Gift (G): 3,000 @ $0 · Gift (G): 3,000 @ $0 | EDGAR |
| 2026-08-12 | 4 | Guyer William — Chief Development Officer | Option exercise (M): 16,300 @ $21.65 · Sale (S): 11,530 @ $113.18 · Sale (S): 4,770 @ $114.04 · Option exercise (M): 16,300 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | Maduck Sean — See Remarks | Option exercise (M): 1,031 @ $8.27 · Sale (S): 1,031 @ $114.52 · Option exercise (M): 1,031 (derivative) @ $0 | EDGAR |
| 2026-08-06 | 4 | Guyer William — Chief Development Officer | Option exercise (M): 3,700 @ $21.65 · Sale (S): 3,700 @ $113.12 · Option exercise (M): 3,700 (derivative) @ $0 | EDGAR |
| 2026-08-05 | 4 | Maduck Sean — See Remarks | Option exercise (M): 20,305 @ $8.27 · Sale (S): 20,305 @ $114.70 · Option exercise (M): 20,305 (derivative) @ $0 | EDGAR |
| 2026-08-05 | 4 | Lyon Joseph Douglas — See Remarks | Sale (S): 1,540 @ $114.16 | EDGAR |
| 2026-08-03 | 4 | Mokari Atabak — Chief Financial Officer | Option exercise (M): 80,000 @ $23.06 · Sale (S): 4,200 @ $105.54 · Sale (S): 8,956 @ $106.96 · Sale (S): 400 @ $108.46 · Sale (S): 2,202 @ $110.03 · Sale (S): 600 @ $110.95 · +9 more | EDGAR |
| 2026-07-17 | 4 | WILSON JAMES N — Director | Sale (S): 1,079 @ $86.78 · Sale (S): 3,969 @ $87.74 · Sale (S): 2,974 @ $88.81 · Sale (S): 1,978 @ $89.49 | EDGAR |
| 2026-07-17 | 4 | Mokari Atabak — Chief Financial Officer | Option exercise (M): 15,833 @ $19.26 · Option exercise (M): 24,167 @ $23.06 · Sale (S): 7,919 @ $86.78 · Sale (S): 28,460 @ $87.89 · Sale (S): 3,520 @ $88.30 · Sale (S): 101 @ $89.43 · +2 more | EDGAR |
| 2026-07-08 | 4 | Robb Gary Charles — Chief Business Officer | Gift (G): 600 @ $0 | EDGAR |
| 2026-07-08 | 4 | Guyer William — Chief Development Officer | Option exercise (M): 20,000 @ $21.65 · Sale (S): 19,048 @ $93.11 · Sale (S): 952 @ $93.54 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2026-07-06 | 4 | Maduck Sean — See Remarks | Option exercise (M): 25,000 @ $8.27 · Sale (S): 11,024 @ $87.33 · Sale (S): 2,801 @ $88.51 · Sale (S): 11,175 @ $89.31 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2026-06-18 | 4 | WILSON JAMES N — Director | Sale (S): 4,177 @ $82.69 · Sale (S): 5,823 @ $83.57 | EDGAR |
| 2026-06-18 | 4 | MAHONEY DAVID L — Director | Sale (S): 20,000 @ $84.53 | EDGAR |
| 2026-06-17 | 4 | Mokari Atabak — Chief Financial Officer | Option exercise (M): 40,000 @ $19.26 · Sale (S): 9,434 @ $80.02 · Sale (S): 11,081 @ $80.94 · Sale (S): 19,483 @ $81.81 · Sale (S): 2 @ $82.45 · Option exercise (M): 40,000 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Guyer William — Chief Development Officer | Option exercise (M): 20,000 @ $21.65 · Sale (S): 20,000 @ $70.60 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Lyon Joseph Douglas — See Remarks | Grant/award (A): 537 @ $70.44 · Grant/award (A): 537 @ $0 · Tax withholding (F): 269 @ $70.44 | EDGAR |
| 2026-06-03 | 4 | Guyer William — Chief Development Officer | Grant/award (A): 877 @ $70.44 · Grant/award (A): 877 @ $0 | EDGAR |
| 2026-06-03 | 4 | Maduck Sean — See Remarks | Option exercise (M): 25,000 @ $8.27 · Sale (S): 21,069 @ $70.11 · Sale (S): 3,931 @ $70.75 · Grant/award (A): 615 @ $70.44 · Grant/award (A): 615 @ $0 · Tax withholding (F): 452 @ $70.44 · +1 more | EDGAR |
| 2026-06-03 | 4 | Mokari Atabak — Chief Financial Officer | Option exercise (M): 40,000 @ $19.26 · Sale (S): 40,000 @ $70.00 · Grant/award (A): 634 @ $70.44 · Grant/award (A): 634 @ $0 · Tax withholding (F): 395 @ $70.44 · Option exercise (M): 40,000 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Robb Gary Charles — Chief Business Officer | Grant/award (A): 776 @ $70.44 · Grant/award (A): 776 @ $0 · Tax withholding (F): 358 @ $70.44 | EDGAR |
| 2026-06-02 | 4 | BELANOFF JOSEPH K — Chief Executive Officer, Director | Gift (G): 300,000 @ $0 · Gift (G): 150,000 @ $0 · Gift (G): 150,000 @ $0 · Sale (S): 12,837 @ $69.74 | EDGAR |
| 2026-05-29 | 4 | Lyon Joseph Douglas — See Remarks | Sale (S): 5,000 @ $65 | EDGAR |
| 2026-05-29 | 4 | Maduck Sean — See Remarks | Option exercise (M): 75,000 @ $8.27 · Sale (S): 54,575 @ $65.37 · Sale (S): 20,425 @ $66.16 · Option exercise (M): 75,000 (derivative) @ $0 | EDGAR |
| 2026-05-29 | 4 | WILSON JAMES N — Director | Gift (G): 892,056 @ $0 · Gift (G): 9,011 @ $0 · Gift (G): 9,011 @ $0 | EDGAR |
| 2026-05-26 | 4 | Murray Joshua M. — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2026-05-26 | 4 | MAHONEY DAVID L — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2026-05-26 | 4 | Park Kimberly — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
Recent 8-K events — CORCEPT THERAPEUTICS INC
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-23 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-29 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-17 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-03 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-05-28 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-30 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-25 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-24 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-19 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-22 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CORT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →